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Summary: The Cardiac syndrome X includes patients, mainly women, with the triad 
of angina pectoris, a positive exercise electrocardiogram for myocardial ischemia and 
angiographically smooth coronary arteries. The most common manifested clinical 
symptom in those patients is chest pain. In most cases, the syndrome is associated 
with debilitating symptomology, increased psychological morbidity and a poor quality 
of life. All the heterogeneity of the syndrome makes the treatment approaches to those 
patients unclear and uncertain. 
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1. INTRODUCTION 
 
The concept of cardiac syndrome X includes patients, mostly 
women, before or in their period of menopause fulfilling the 
following three criteria: chest pain, positive exercise-strain test, 
normal coronary angiogram [1, 2, 10]. The chest pain is a leading 
symptom of these patients, usually stronger and more prolonged than 
the typical angina pectoris, which is also more difficult to control by 
the standard antiischemic therapy [3, 7]. As a result, patients are 
repeatedly re-hospitalised, new unnecessary angiograms are being 
done and quality of life of these patients worsens [4]. 
 
Some clinical studies related to prognosis of these patients show that 
their life-expectancy does not differ considerably from the rest of the 
population, excluding those with rhythm and conductance disorders 
such as left-bundle branch block who develop dilatated  cardiomyo-
pathy more frequently (NLHBI WISE study with mean duration of 
follow-up- 5.2 years) [5]. 
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In May 2009 [5] the results from St. James Women Take Heart 
(WTH) Project were announced. The project gives two main results. 
The first one is that “…women with symptoms and signs suggestive 
of ischemia, but without obstructive CAD are at elevated risk for 
cardiovascular events compared with asymptomatic community-
based women”. The second one defines that based on the finding 
from this and other studies, linking endothelial dysfunction and 
future cardiovascular events, it is recommendable that all women 
with symptoms suggestive of ischemia undergo initial evaluation for 
obstructive CAD, and if there is no evidence of obstructive CAD, 
such women need further assessment for endothelial dysfunction. 
 
All these give enough reasons for further investigation, despite that 
all cardiac syndrome X keep being diagnostically and therapeutically 
obscure. Many authors work on finding the pathogenesis of this 
syndrome: 
1.  myocardial ischemia, 
2.  endothelial dysfunction, 
3.  metabolic and hormonal factors, 
4.  change in pain perception.  
 
Heterogeneous pathogenesis of cardiac syndrome X makes 
therapeutic approach undefined [2]. 
 
Statistical data show that not less than 33% of women exhibiting 
typical angina chest pain have clear coronary vessels, proved by 
selective coronary angiogram [5]. 
 
The aim of the study is to investigate the changes in the LV kinetics 
and the perfusion-reversible or not reversible changes in patients 
with cardiac syndrome X.  
 
2. MATERIAL AND METHODS 
 
A prospective randomized study includes 18 consecutive patients 
(women) at the mean age 55.29±9,47 who have fulfilled the criteria 
for cardiac syndrome X, hospitalized in the Clinic of Cardiology, 
Department of Internal Medicine, Medical University of Sofia, and 
who are selected from the four cath-Labs in Sofia. 
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All randomized patients with Cardiac Syndrome X in the study 
underwent Myocardial perfusion SPECT CT. Before performing 
the study, all patients were carefully made familiar with the protocol 
of the study. 
 
The protocol of the study includes rest and stress SPECT and after 
application of nitrates with depot effect.  
 
Radiopharmaceutical: 99m Tc Tetrofosmin. Single day protocol. 
Activity applied: 250 MBq at exertion and 750 MBq at rest with total 
activity- 1000 MBq. Records are made at exertion on the 30 min. 
after the application of the radiopharmaceutical and on the 1 and 2 h 
at the rest. Just after the first record at rest, patients are given per os 
10 mg Isodinit. All records are made in γ-camera SPECT-CT with 
ECG synchronization. Framing - eight frames for a cardiac cycle.  
 
Stress test: treadmill. Step by step exertion until the patient 
complains from chest pain or ECG changes in the repolarization. If 
there are no such complains, the test continues until reaching 90% 
from the maximum calculated heart rate. The radiopharmaceutical is 
infused at the maximal exertion.  
 
Interpretation: point of interest were the changes in the perfusion 
(reversible or not reversible), and the left ventricle (LV) kinetics. 
Using the quantitative gated SPECT (QGS), the total defect in 
perfusion was calculated in percentage of the myocardium of the LV. 
The following parameters were defined: total exertion, rest and 
differential scores: summed stress score (SSS), summed rest score 
(SRS), summed difference score (SDS). The following parameters of 
LV function were calculated at rest and exertion: ejection fraction of 
the left ventricle (EFLV), end diastolic volume (EDV), end systolic 
volume (ESV), max velocities of filling and ejection: peak empting 
rate (PER), peak filling rate (PFR). 
 
3. RESULTS 
 
Changes in the LV kinetics were found in 3 patients (16.7%): 2 with 
perfusion defect (1 with no change at rest) and 1 without such defect 
(Fig. 1). 
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Fig. 1 Patients from the studied group with data from SPECT CT 
for changes in myocardial kinetics 
 
In 10 (55.6%) patients from the studied group there were different 
degrees of perfusion abnormalities: SDS max 9, min 2, mean 
3.6±2.497 (Fig. 2). From patients with SDS > 0.6 (60%) recovered at 
rest and 2 (20%) normalized after receiving nitrates with depot 
effect. 
 
Fig. 2 Distribution of patients according to perfusion disorders 
 
Comparing parameters of systolic function in patients with perfusion 
defects there was not significant increase of EFLV (p = 0.235) 
(Fig. 3) and no significant change of the ESV (p = 0.498) (Fig. 4). 
There is a preserved reaction of stress of the PER (p = 0.05) in those 
patients but no significant difference of the PFR (p = 0.674) as a 
parameter of diastolic function (Fig. 5). 
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In patients without perfusion defects, there is a preserved reaction to 
stress of the EFLV (p = 0.08) (Fig. 6) and the parameter of diastolic 
function PFR (p = 0.068) (Fig. 7). 
 
Fig. 3 EFLV at rest and stress in patients with perfusion disorder 
(p = 0.235) 
 
Fig. 4 ESV at rest and stress in patients with perfusion disorder 
(p = 0.498) 
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Fig. 5 PFR at rest and stress in patients with perfusion disorder 
(p = 0.674) 
 
Fig. 6 EFLV at rest and stress in patients without perfusion disorder 
(p = 0.08) 
 
Fig. 7 PFR at rest and stress in patients without perfusion disorder 
(p = 0.068) 
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4. DISCUSSION 
 
One of the most discussed ideas for the origin of cardiac syndrome X 
is myocardial ischemia. Publications suggest contradictory opinions 
about this idea. Cannon et al. proved that patients with disturbed 
coronary vasodilative reserve had decreased left-ventricle ejection 
fraction (EF) during states of increased strain compared to those with 
preserved coronary reserve
2. They concluded that these patients had 
signs of myocardial ischemia. Sax et al. investigated systemic 
vasodilative response by a method based on venous pletismography 
in order to compare patients to healthy controls
11. Their results 
showed a 21% decrease of vasodilative response in patients with 
cardiac X syndrome, appearing on the 3rd minute. The authors also 
found significantly increased vessel resistance in this group of 
patients. Supported by these results, Cannon concludes that Х-
syndrome is based on small coronary vessel dysfunction, i.e. 
“microvascular angina”
 [2, 3]. 
 
5. CONCLUSION 
 
The results of the current study demonstrate that in patients with 
criteria for cardiac syndrome X there are more marked changes in 
the myocardial perfusion, which usually are not connected with 
changes in the kinetics. In those patients, there is no adequate 
increase of EFLV, which is probably related to the disturbed 
diastolic function assessed by PFR. These results correlates with 
previous studies that have demonstrated the presence of myocardial 
fibrosis in these patients.  
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